146 related articles for article (PubMed ID: 30572722)
1. Epidemiology of ATTRV30M neuropathy in Cyprus and the modifier effect of complement C1q on the age of disease onset.
Andreou S; Panayiotou E; Michailidou K; Pirpa P; Hadjisavvas A; El Salloukh A; Barnes D; Antoniou A; Agathangelou P; Papastavrou K; Christodoulou K; Tanteles GA; Kyriakides T
Amyloid; 2018 Dec; 25(4):220-226. PubMed ID: 30572722
[TBL] [Abstract][Full Text] [Related]
2. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
Dardiotis E; Koutsou P; Zamba-Papanicolaou E; Vonta I; Hadjivassiliou M; Hadjigeorgiou G; Cariolou M; Christodoulou K; Kyriakides T
J Neurol Sci; 2009 Sep; 284(1-2):158-62. PubMed ID: 19493541
[TBL] [Abstract][Full Text] [Related]
3. C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy.
Panayiotou E; Fella E; Papacharalambous R; Malas S; Saraiva MJ; Kyriakides T
PLoS One; 2017; 12(4):e0175767. PubMed ID: 28407005
[TBL] [Abstract][Full Text] [Related]
4. The frequency of central nervous system complications in the Cypriot cohort of ATTRV30M neuropathy transplanted patients.
Dardiotis E; Andreou S; Aloizou AM; Panayiotou E; Siokas V; Ioannou MN; Vounou E; Christodoulou K; Tanteles GA; Michaelides D; Kyriakides T
Neurol Sci; 2020 May; 41(5):1163-1170. PubMed ID: 31897943
[TBL] [Abstract][Full Text] [Related]
5. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y
J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547
[TBL] [Abstract][Full Text] [Related]
6. New data on the genetic profile and penetrance of hereditary Val30Met transthyretin amyloidosis in Sweden.
Gorram F; Olsson M; Alarcon F; Nuel G; Anan I; Planté-Bordeneuve V
Amyloid; 2021 Jun; 28(2):84-90. PubMed ID: 33146042
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus.
Dardiotis E; Koutsou P; Papanicolaou EZ; Vonta I; Kladi A; Vassilopoulos D; Hadjigeorgiou G; Christodoulou K; Kyriakides T
Amyloid; 2009 Mar; 16(1):32-7. PubMed ID: 19291512
[TBL] [Abstract][Full Text] [Related]
8. Anticipation on age at onset in kindreds with hereditary ATTRV30M amyloidosis from the Majorcan cluster.
Cisneros-Barroso E; González-Moreno J; Rodríguez A; Ripoll-Vera T; Álvarez J; Usón M; Figuerola A; Descals C; Montalá C; Ferrer-Nadal MA; Losada I
Amyloid; 2020 Dec; 27(4):254-258. PubMed ID: 32633140
[TBL] [Abstract][Full Text] [Related]
9. A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal.
Alves-Ferreira M; Coelho T; Santos D; Sequeiros J; Alonso I; Sousa A; Lemos C
Mol Neurobiol; 2018 May; 55(5):3676-3683. PubMed ID: 28527106
[TBL] [Abstract][Full Text] [Related]
10. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
[TBL] [Abstract][Full Text] [Related]
11. A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers.
Olsson M; Norgren N; Obayashi K; Plante-Bordeneuve V; Suhr OB; Cederquist K; Jonasson J
BMC Med Genet; 2010 Sep; 11():130. PubMed ID: 20840742
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.
Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P
Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568
[TBL] [Abstract][Full Text] [Related]
13. Variants in RBP4 and AR genes modulate age at onset in familial amyloid polyneuropathy (FAP ATTRV30M).
Santos D; Coelho T; Alves-Ferreira M; Sequeiros J; Mendonça D; Alonso I; Lemos C; Sousa A
Eur J Hum Genet; 2016 May; 24(5):756-60. PubMed ID: 26286643
[TBL] [Abstract][Full Text] [Related]
14. Extremely Early Onset Transthyretin Familial Amyloid Polyneuropathy with a Leu55Pro Mutation: A Pediatric Case Report and Literature Review.
Lee YJ; Oh J; Hwang SK; Lee EJ; Yang DH; Kim YJ; Kwon S; Hyun MC
Neuropediatrics; 2019 Oct; 50(5):322-326. PubMed ID: 31319424
[TBL] [Abstract][Full Text] [Related]
15. Impact of liver transplantation on the natural history of oculopathy in Portuguese patients with transthyretin (V30M) amyloidosis.
Beirão JM; Malheiro J; Lemos C; Matos E; Beirão I; Pinho-Costa P; Torres P
Amyloid; 2015 Mar; 22(1):31-5. PubMed ID: 25475560
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M
J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945
[TBL] [Abstract][Full Text] [Related]
17. TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?
Bonaïti B; Olsson M; Hellman U; Suhr O; Bonaïti-Pellié C; Planté-Bordeneuve V
Eur J Hum Genet; 2010 Aug; 18(8):948-52. PubMed ID: 20234390
[TBL] [Abstract][Full Text] [Related]
18. Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca.
Cisneros-Barroso E; Gorram F; Ribot-Sansó MA; Alarcon F; Nuel G; González-Moreno J; Rodríguez A; Hernandez-Rodriguez J; Amengual-Cladera E; Martínez-López I; Ripoll-Vera T; Losada-López I; Heine-Suñer D; Plante-Bordeneuve V
Orphanet J Rare Dis; 2023 Aug; 18(1):255. PubMed ID: 37653545
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease.
Soares ML; Coelho T; Sousa A; Batalov S; Conceição I; Sales-Luís ML; Ritchie MD; Williams SM; Nievergelt CM; Schork NJ; Saraiva MJ; Buxbaum JN
Hum Mol Genet; 2005 Feb; 14(4):543-53. PubMed ID: 15649951
[TBL] [Abstract][Full Text] [Related]
20. Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis.
Ihse E; Rapezzi C; Merlini G; Benson MD; Ando Y; Suhr OB; Ikeda S; Lavatelli F; Obici L; Quarta CC; Leone O; Jono H; Ueda M; Lorenzini M; Liepnieks J; Ohshima T; Tasaki M; Yamashita T; Westermark P
Amyloid; 2013 Sep; 20(3):142-50. PubMed ID: 23713495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
